For those in healthcare. By those in healthcare.
facebook
LinkedIn
twitter

Zoeticx leverages crowd funding to introduce TruRecord, medical prescribing software that will address 2.2 million adverse drug reactions in U.S

Zoeticx, the developer of medical software that bridges the gap between medical data and quality patient care, announced a crowd funding campaign for TruRecord, the first subscriber-based, medical prescribing software to leverage advanced DNA testing technology for optimal drug analysis and prevention of adverse drug reactions.

The company is raising funds for a fall launch of TruRecord on medical crowd funding site Medstartr http://www.medstartr.com/projects/662-trurecord

TruRecord improves patient outcomes by reducing the 80,000 annual deaths due to drug adverse reactions, resulting in 289 billion spent annually on malpractice payouts. CDC ranks this as the fourth highest cause of deaths in US. With 30 new medications introduced yearly and 25 percent of patients on multiple medications, the need is growing.  The CDC also ranks this as the fourth highest cause of death in the U.S. after heart disease, cancer and strokes.

TruRecord is designed to foster better patient outcomes by helping to prevent the 100,000 deaths yearly from drugs that are prescribed properly and 80,000 deaths from those which are not, resulting in 289 billion spent annually on malpractice payouts.

Breaking through drug analysis limitations

Through an intuitive visualization of drug-to-drug interactions, drug-to-allergy interactions, and drug to DNA metabolization, medical professionals can now create what-if scenarios for drug issues, enabling providers to personalize prescriptions. This capability breaks through providers’ drug analysis limitations and the burdensome task of scanning and searching text and tables to identify adverse reaction data which is often complex.

These scenarios can now also be more complete with accurate patient medical information from any facility, including integration from existing hospital EHR’s through Zoeticx’s Patient-Clarity Platform which connects disparate EHR records and enables medical system interoperability.

Mobile devices, HIPAA compliance

TruRecord client interfaces are supported on mobile and web interfaces, providing precise, personalized medication prescription. TruRecord accesses patient medical records via an on-demand, real time access from EHR and EMR systems. Without data duplication, TruRecord complies with all required secure patient privacy protections outlined by HIPAA.

“We built Zoeticx to help medical systems address interoperability, lower accidental deaths and bridge the gap between medical data and better patient outcomes,” said Thanh Tran, CEO, Zoeticx. “Today our goal is the same, but a shift toward an additional focus—adverse drug reactions. We are ushering in an era where we can leverage the fruits of DNA research to bring more precise and accurate prescriptions to those who rely on them. TruRecord takes the guess work out of drug interactions and patients by delivering security, peace of mind and accuracy.”

crowd funding, drug to DNA metabolization, drug-to-allergy interactions, drug-to-drug interactions, EHR, EMR, HIPAA Compliance, interoperability, subscriber-based, TruRecord, Zoeticx

Social

Please follow and ‘Like’ us
©2019 HIT Leaders and News LLC. All rights reserved.
%d bloggers like this: